On-body Injector Patient Instructions for Use:

Which version of the Instructions for Use did your doctors's office give you?

I have this folded version

I have this full-color booklet version

If you don’t recognize the images above or if you prefer a physical copy, contact your doctor.

Onpro® Kit HCP Instructions for Use:

Which version of the Instructions for Use came with your patient's on-body injector?




This version




This version

Indication

Neulasta® (pegfilgrastim) is a prescription medicine used to help reduce the... Read More

You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to return to the consumer site, please click CANCEL.

Continue Cancel

Most prescriptions cost $5 or less out of pocket per dose for Neulasta® PFS and Neulasta® Onpro®

The majority of commercial and Medicare plans cover Neulasta® PFS and Neulasta® Onpro®

For more information on paying for Neulasta® Onpro®, find your insurance type below.

Amgen is committed to help ensure you will be able to get Neulasta® Onpro® at an affordable cost.

As of Q1 2024 the list price for Neulasta® is $6,418.0* per dose. Neulasta® is a single dose administered once per chemotherapy cycle. Most patients do not pay the list price. Your actual cost will vary. Talk to your insurance provider.

*List price is also referred to as wholesale acquisition cost or WAC. WAC is the price at which Amgen sells its products to wholesalers.

Personalized support designed for you

Connect with us live: Call 866 264-2778

Monday through Friday — 9:00 AM to 8:00 PM ET
Across all insurance types, a majority of patients pay $5 or less per dose* for Neulasta Onpro.

*These data are based on paid claims data from national data providers for the period from 01/01/23 through 12/31/23. Your actual cost may vary depending on your dose, insurance coverage, and eligibility for support programs. Talk to your insurance provider for specific information about your prescription coverage.

I have commercial insurance

(eg, self-purchased or through an employer)


copay card icon
copay card icon

Amgen® SupportPlus Co-Pay Program

Amgen® SupportPlus Co-Pay Program

If you have private or commercial insurance that you get from your employer or buy directly from a health insurance company, you may be eligible to pay as little as $0† for your prescription.
  • Pay as little as $O† out-of-pocket for each dose
  • Can be applied to deductible, co-insurance, and co-payment†
  • No income eligibility requirement

Encourage your patients with private or commercial insurance to check eligibility and enroll.

Visit Amgen SupportPlus Co-Pay Program now
copay card image

†Eligibility criteria and program maximums apply. See AmgenSupportPlus.com/Copay for full Terms and Conditions.

What if I don’t have private or commercial insurance?

(eg, self-purchased or through an employer)

Amgen® SupportPlus can provide information about independent nonprofit foundations that may be able to help.*

Call Amgen® SupportPlus at 866-264-2778 Monday - Friday 9:00 AM to 8:00 PM ET to learn more.

*Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofits’ criteria. Amgen has no control over these programs and provides referrals as a courtesy only.

amgen-nurse-patners
amgen-nurse-patners

Amgen® Nurse Partners

Amgen® Nurse Partners

Dedicated Amgen® Nurse Partners* can offer supplemental support to help you on your treatment journey, including:

  • Guidance on resources that may help lower out-of-pocket medication costs
  • Assistance to help you stay on track with your medication
  • Answers to your questions about Amgen SupportPlus
Get connected with a dedicated Amgen Nurse Partner by enrolling in Amgen SupportPlus:
Download and complete the Amgen SupportPlus Enrollment Form found on AmgenSupportPlus.com and give it to your doctor to complete and fax to 1-888-407-9787. Call 866-264-2778 to enroll by phone.

*Amgen Nurse Partners are only available to patients that are prescribed certain Amgen products. They are not part of your treatment team and do not provide medical advice, nursing, or case-management services. Nurse Partners will not inject patients with Amgen medications. Patients should always consult their healthcare provider regarding medical decisions or treatment concerns.

Explore Tools & Resources

patient-brochure-bw-png

Neulasta® Onpro® Brochure
Get an overview of Neulasta® and the Neulasta® Onpro® kit.

download-w-svg

Important Safety Information

Do not take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.

Before you receive Neulasta®, tell your healthcare provider about all of your healthcare conditions, including if you:
  • Have a sickle cell disorder
  • Have had severe skin reactions to acrylic adhesives
  • Are allergic to latex – The needle cap on the prefilled syringe contains dry natural rubber (derived from latex).
  • Have kidney problems
  • Are pregnant or plan to become pregnant. It is not known if Neulasta® may harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if Neulasta® passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible serious side effects of Neulasta®?
  • Spleen Rupture. Your spleen may become enlarged and can rupture while taking Neulasta®. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder tip area.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
  • Serious Allergic Reactions. Neulasta® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate and sweating.
If you have an allergic reaction during the delivery of Neulasta®, remove the on-body injector for Neulasta® by grabbing the edge of the adhesive pad and peeling off the on-body injector. Get emergency medical help right away.
  • Sickle Cell Crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive Neulasta®.
  • Kidney injury (glomerulonephritis). Neulasta® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face or ankles, blood in your urine or dark colored urine, or you urinate less than usual.
  • Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with Neulasta®.
  • Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with Neulasta®. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with Neulasta®. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot.
  • Capillary Leak Syndrome. Neulasta® can cause fluid to leak from blood vessels into your body’s tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:
    • Swelling or puffiness and are urinating less than usual
    • Trouble breathing
    • Swelling of your stomach area (abdomen) and feeling of fullness
    • Dizziness or feeling faint
    • A general feeling of tiredness
  • Myelodysplastic syndrome and acute myeloid leukemia. If you have breast cancer or lung cancer, when Neulasta® is used with chemotherapy and radiation therapy, or with radiation therapy alone, you may have an increased risk of developing a precancerous blood condition called myelodysplastic syndrome (MDS) or a blood cancer called acute myeloid leukemia (AML). Symptoms may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop these symptoms during treatment with Neulasta®.
  • Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received Neulasta®. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.

The most common side effect of Neulasta® is pain in your bones and in your arms and legs.

These are not all the possible side effects of Neulasta®. Call your healthcare provider for medical advice about side effects. You may report negative side effects to the FDA at 1-800-FDA-1088.

Please see Neulasta® Patient Information.

Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only.

Neulasta® Injection: 6 mg/0.6 mL in a single-dose prefilled syringe co-packaged with the on-body injector (OBI) for Neulasta® (Neulasta® Onpro® kit).

Important Safety Information
Do not take Neulasta® if you have had a serious allergic reaction to pegfilgrastim or filgrastim.
Before you receive Neulasta®, tell your healthcare provider about all of your healthcare conditions, including if you:
• Have a sickle cell disorder
• Have had severe skin reactions to acrylic adhesives